Epitope mismatches for HEM platelets and match grades for HSM platelets
| . | Transfusions . | |
|---|---|---|
| Evaluable trial . | Nonevaluable trial . | |
| Epitope mismatches (HEM) | (n = 107) | (n = 97) |
| N | 105 | 95 |
| Median | 3 | 2 |
| Q1-Q3 | 0-6 | 0-6 |
| Minimum to maximum | 0-15 | 0-16 |
| Mean (SD) | 3.6 (4) | 3.7 (4.5) |
| Grade (HSM), n (%)* | (n = 112) | (n = 95) |
| A | 57 (52) | 37 (39) |
| B1 | 36 (33) | 34 (36) |
| B2 | 13 (12) | 19 (20) |
| B3 | 3 (3) | 3 (3) |
| B4 | 1 (1) | 1 (1) |
| . | Transfusions . | |
|---|---|---|
| Evaluable trial . | Nonevaluable trial . | |
| Epitope mismatches (HEM) | (n = 107) | (n = 97) |
| N | 105 | 95 |
| Median | 3 | 2 |
| Q1-Q3 | 0-6 | 0-6 |
| Minimum to maximum | 0-15 | 0-16 |
| Mean (SD) | 3.6 (4) | 3.7 (4.5) |
| Grade (HSM), n (%)* | (n = 112) | (n = 95) |
| A | 57 (52) | 37 (39) |
| B1 | 36 (33) | 34 (36) |
| B2 | 13 (12) | 19 (20) |
| B3 | 3 (3) | 3 (3) |
| B4 | 1 (1) | 1 (1) |
Mismatch was not reported for 2 evaluable and 2 nonevaluable HEM transfusions, and grade was not reported for 2 evaluable and 1 nonevaluable HSM transfusion.
Q, quartile.
Column percentages are shown.